two new injectable diabetes drugs, Byetta (exenatide) and Symlin (pramlintide)
June 2005
There's excitement about two new injectable diabetes drugs, Byetta (exenatide) and Symlin (pramlintide).
These drugs are the first of their kind. They mimic hormones that help regulate blood glucose.
Byetta is an incretin mimetic. Incretins are secreted by the GI tract after meals. They stimulate insulin secretion...slow stomach emptying...and reduce hunger.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote